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ABSTRACT 
 
 
 Campylobacter rectus is a Gram-negative oral anaerobe and a causative agent of 
periodontitis. Additionally, C. rectus strains have been isolated from patients with oral 
and extraoral abscesses, gingival crevices, and appendicitis. This organism has been 
implicated in bacteremia and is associated with pre-term births and low birth weight, 
indicating its importance as an emerging pathogen. The goal of this thesis was to 
establish genetic tools to begin clarifying mechanisms responsible for C. rectus 
pathogenesis. In particular, secretion systems identified as important for pathogenesis in 
related bacterial species were selected for further study. Bacterial-host interaction assays 
were used to identify host responses stimulated by the CiaB protein as well as the role of 
the Hcp protein in host cell adherence. Toward this goal, complete deletions of the ciaB 
and the hcp genes were generated in C. rectus and reference genes for RT-qPCR in C. 
rectus were validated to permit assessment and verification of the mutant strains.  Host 
response was assessed by exposing a human placental epithelial cell line, BeWo, to both 
C. rectus wild-type and ciaB mutant strains for six-hours under anaerobic conditions and 
inflammatory mRNA expression was measured using RT-qPCR. A significant 
upregulation in 41 inflammatory genes was measured in response to ΔciaB while only 
three were significantly upregulated in response to wild-type. THP-1 human monocyte 
cell viability was also assessed over a 96-hour time course after exposure to wild-type 
and ΔciaB. Additionally, adherence efficiencies of wild-type and Δhcp to BeWo cells 
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were calculated after a one-hour time point. Adherence rates between wild-type and 
Δhcp were not significantly different. The studies in this thesis suggest C. rectus uses 
CiaB as a mechanism to evade the host cell immune response. Analysis of the Δhcp 
mutant prepared this strain for further studies like those used for the CiaB mutant strain 
to fully characterize the importance of the type VI secretion system to C. rectus 
virulence. Results from this foundational thesis research will expedite future studies 
examining the underlying molecular mechanisms of C. rectus pathogenesis. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
The discovery, features, and metabolic properties of Campylobacter rectus 
Campylobacter rectus is a Gram-negative anaerobic bacterium and a causative agent 
of periodontal disease. C. rectus is a small, straight rod that is typically 0.5 µm wide and 
4 µm long and possesses a single polar flagellum which provides motility [1, 2]. 
Originally named Wolinella recta in 1981 by Tanner et al. [2], it was later reclassified 
into the Campylobacter genus in 1991 by Vandamme et al. [3] following more extensive 
rRNA sequence analysis.  
C. rectus grows optimally under anaerobic conditions with media containing 
mycoplasma broth supplemented with formate and fumarate and is unable to use 
carbohydrates for fermentative growth [4]. C. rectus  has a formate-fumarate driven 
metabolism and uses formate or hydrogen from other oral species as electron donors 
while fumarate and nitrate act as an electron acceptor for metabolism [4, 5]. The use of 
formate and fumarate from other oral organisms signifies a symbiotic relationship 
between C. rectus and other oral bacteria, indicating the existence of a complex 
microbiota of the oral milieu is pertinent to optimal growth conditions and pathogenesis 
of C. rectus.  
The connection between Campylobacter rectus and adverse health outcomes 
Periodontal disease is caused by a plethora of oral pathogenic bacteria and is often 
characterized using the microbial complex [6]. C. rectus is classified as an intermediate 
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oral pathogen and is labeled in the “orange complex” [6]. The exact role of each 
bacterium in periodontal disease is relatively unknown, however the initial colonizers of 
the complex, such as Streptococcus and Actinomyces species, are able to colonize and 
provide the necessary environment for more intermediate pathogenic bacteria, including 
C. rectus and Fusobacterium nucleatum, to colonize. The presence of these intermediate 
oral pathogens creates the ideal environment for the most aggressive oral pathogens: 
Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola [6, 7]. 
Periodontitis affects 47% of adults in the United States and C. rectus being present in 
90% of those cases [8]. C. rectus is most commonly isolated from periodontal locations 
[9], however strains have been isolated from other regions of the body such as extraoral 
abscesses [10], gingival crevices [11], and appendicitis cases [12].  Furthermore, C. 
rectus has been detected in peripheral blood from orally infected patients as well as in 
placental tissue from infected mice [13], and is known to be associated with adverse 
human pregnancy outcomes such as low birth weight and preterm labor [10, 14]. 
Estradiol and progesterone stimulate the growth of C. rectus in vitro and correlates with 
increased physiological levels of estradiol in pregnant women [14, 15]. Additionally, 
when compared to their healthy counterparts, pregnant women with increased levels of 
C. rectus present in their oral microbiome were more likely to have gum bleeding and 
deep periodontal pocket depth [15]. The association of periodontal disease and adverse 
pregnancy outcomes make C. rectus an increasingly important organism to study in 
human health. 
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Characteristics of Campylobacter rectus 
Lipopolysaccharide 
Although it is well-established that C. rectus is a causative agent of periodontal 
disease, the methods of pathogenesis associated with C. rectus are largely understudied 
and as a result, not well understood.  However, previous studies have discovered C. 
rectus produces several virulence factors including lipopolysaccharide (LPS) [16]. LPS 
is a common virulence factor in Gram-negative bacteria and is known in C. rectus 33238 
to stimulate the plasminogen activator-plasmin system to release prostaglandin E and 
interleukin (IL)-1 from human gingival fibroblast (HGF) cells [17, 18]. Although LPS 
isolated from C. rectus 33238 has been shown to stimulate inflammation, its presence is 
not necessary for toxic effects [16]. Furthermore, C. rectus 33238 LPS has activity 
similar to LPS isolated from Escherichia coli [19].  
Surface layer 
Another characterized virulence factor of C. rectus is the surface-layer protein (s-
layer). The s-layer of C. rectus is a paracrystalline cell surface structure and seems to 
play a role in altering host-pathogen interactions [20, 21]. Studies have shown that C. 
rectus 33238 loses its s-layer after 15 to 17 in vitro passages and isolates lacking the s-
layer are less virulent in a mouse abscess model [22, 23]. S-layer-positive isolates are 
more resistant to phagocytosis by leukocytes or to complement-mediated killers [24]. 
Finally, a mutation in the s-layer of  C. rectus 314 and 33238 decreases binding to 
epithelial cells and the C. rectus 314 s-layer mutant stimulates increased expression of 
pro-inflammatory cytokines from epithelial cells [21]. These discoveries about the s-
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layer function are essential in beginning to understand the mechanisms behind C. rectus 
pathogenesis.  
Toxins 
  Cytotoxic activities have been reported in C. rectus and are suggested to be caused 
by pore-forming protein toxins in the RTX (repeats in the structural toxins) family [25]. 
RTX toxins are known to be major virulence factors of many Gram-negative bacteria 
and include the alpha-hemolysin HlyA in E. coli, the leukotoxins AaLtA in 
Aggregatibacter actinomycetemcomintans, and the adenylate cyclase CyaA of 
Bordetella pertussis [26-29]. C. rectus cytotoxic activity was first suggested in 1990, 
discovering that whole cells of C. rectus 33238 suppress the proliferation of 
undifferentiated monomyelocytic HL-60 cells. This study also found both 
undifferentiated and differentiated HL-60 cells are killed post-exposure to live and 
opsonized C. rectus 33238 [30]. Furthermore, heat-killed C. rectus 33238 has decreased 
killing effects when compared to live and opsonized bacteria [30]. Although media 
supernatants from C. rectus 33238 are toxic to HL-60 cells and human 
polymorphonuclear leukocytes (PMNs), whole cell suspensions of C. rectus do not 
appear to have a killing effect [31]. Consequently, Kuhnert et al. [32] found RTX 
protein-coding genes in the C. rectus 33238 genome, terming these genes csxA and csxB 
(C. rectus s-layer-RTX toxin). These toxins are hypothesized to play a role in host 
interactions in other campylobacters [33]. 
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Host response and inflammation stimulation 
 The stimulation of a host response is significant in disease pathogenesis and is a 
vital step in the progression of periodontal disease. Previous studies have indicated 
whole cells and components of C. rectus are capable of stimulating a host response. 
Formalin-killed C. rectus 33238 cells induce the production of interleukin (IL)-6 and IL-
8 from HGF cells, while C. rectus surface associated material (SAM) induces IL-6 
production from HGF, peripheral blood mononuclear cells (PBMCs), and Mono-Mac-6, 
a myelomonocytic cell line [34, 35]. Additionally, LPS from C. rectus 33238 stimulates 
IL-1 secretion from murine macrophages [36]. The s-layer is proposed to play a major 
role in C. rectus pathogenesis as an s-layer mutant in C. rectus 314 and 33238 stimulates 
a significant increase of the pro-inflammatory cytokines IL-6, IL-8, and tumor necrosis 
factor–alpha (TNF-α) from HEp-2 epithelial cells [21]. The production of pro-
inflammatory cytokines is understood to be responsible for the immune response and 
inflammation commonly seen in periodontal disease.  
CiaB as a virulence factor in Campylobacter rectus 
Another strong candidate for virulence of C. rectus is a protein deemed 
Campylobacter invasion antigen B (CiaB), which was first described in C. rectus 314 by 
LaGier and Threadgill in 2014 [37]. This study found C. rectus 314 encodes an 1,830-
base pair ciaB gene, encoding a 69.8 kilodalton (k-Da) protein, which shares a 53% 
sequence identity and 70% similarity with the ciaB gene in C. jejuni. BLASTx analysis 
identified similarity to genes in other species annotated as ciaB, a hypothetical protein, 
and a lipoprotein signal peptidase [37]. Moreover, using as quantitative reverse 
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transcription PCR (RT-qPCR), ciaB was found to be expressed by C. rectus 314, a 
clinical isolate, as well as C. rectus 33238, a periodontal pocket isolate [37, 38]. C. 
rectus ciaB is predicted to be localized to the cytoplasm and does not contain membrane 
helices or a signal peptide [37]. C. rectus ciaB is  necessary for maximal host cell 
invasion of human placental cells (BeWo), but not for maximal adherence [38]. These 
findings indicate C. rectus CiaB possesses a similar function as what is observed in C. 
jejuni, however, the role of CiaB in host responses is still unknown.  
CiaB in other campylobacters  
C. jejuni, a bacterium closely related to C. rectus, utilizes its flagellum as a type 
III secretion system (T3SS) to secrete proteins essential for virulence processes such as 
host cell invasion [39]. C. jejuni proteins that are required for high rates of invasion have 
been termed Campylobacter invasion antigens (Cia). Although approximately 18 Cia 
proteins have been discovered in C. jejuni, only four have been characterized [40-43]. 
The most extensively characterized Cia protein in C. jejuni, CiaB, is a 73 k-Da secreted 
protein and is required for the secretion of all other Cia proteins [42]. Additionally, CiaB 
is vital to host cell invasion, apoptosis, and overall virulence in animal models [42, 44, 
45], however, the underlying molecular mechanisms of C. jejuni CiaB are still unclear. 
Furthermore, the ciaB gene has been identified in other campylobacters such as 
Campylobacter fetus, Campylobacter coli, Campylobacter lari, Campylobacter curvus, 
and Campylobacter concisus [37, 46-48]. The discovery of the ciaB gene in multiple 
campylobacters indicates the gene may play an important role in overall campylobacter 
pathogenesis.  
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Secretion systems as virulence factors  
Secretion systems play a vital role in bacterial pathogenesis by secreting proteins 
or DNA into host cells. Such secreted proteins are vital for numerous things including 
evasion of the immune system, adherence and invasion of host cells, ruffling of the host 
extracellular matrix, and the stimulation of an immune response [45, 49]. Six classes of 
secretion systems have been identified in Gram-negative bacteria: T1SS (type I secretion 
system), T2SS, T3SS, T4SS, T5SS and T6SS [50]. Each secretion system class is noted 
to perform different functions. T1SS, T2SS, and T5SS are classified as delivering 
proteins to the bacterial surface or into the environment while T3SS, T4SS, and T6SS 
are more commonly associated with pathogenesis mechanisms [49, 51]. 
A secretion system often related with bacterial pathogens is the T3SS, which 
distributes proteins directly into eukaryotic cells to stimulate a host response [52]. For 
example, in Campylobacter jejuni, the flagellar T3SS is found to secrete proteins vital to 
host cell interactions, known as the Cia proteins [53]. Similar to C. jejuni, genomic 
research has revealed the presence of a T3SS in C. rectus, however T3SS functionality 
has yet to be verified.  
The function of the most recently discovered secretion system, T6SS, is 
dependent on the bacterial species and has been found to perform many roles, such as 
toxin secretion, stimulation of immune responses from the host cell, anti-virulence to 
evade the immune system, and bacterial competition [54]. The T6SS in some bacteria is 
critical to the adherence and invasion of host cells. For example, in Campylobacter 
jejuni, a 50% reduction in both adherence and invasion to colon epithelial and 
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macrophage cells was observed in T6SS mutants with deletions in hcp, encoding a T6SS 
secreted hemolysin protein, and the T6SS structural icmF gene [55]. Conversely, the 
Helicobacter hepaticus T6SS hinders adherence and invasion. However, previous 
studies observed an increase in adherence and invasion when the T6SS function was 
inactivated, suggesting that H. hepaticus may utilize its T6SS as a survival function [56].   
Current genomic research has identified the presence of a T3SS and T6SS in the C. 
rectus genome, however it is still unknown how these systems contribute to C. rectus 
pathogenesis. In the following chapters, research aimed at investigating CiaB and the 
T3SS as well as Hcp and the T6SS will be discussed to address some important features 
of these two systems in C. rectus. In particular, the importance of these two systems to 
host interactions will be explored. 
Campylobacter rectus 33238 and 314 characteristics 
C. rectus 33238 is the only publically sequenced strain. This strain was isolated from 
a periodontal pocket and is currently a well-established laboratory strain of C. rectus 
[57]. C. rectus 33238 was sequenced in 2008 by the J. Craig Venter Institute as a 
reference genome for the species. Genomic sequence revealed that this strain has a 
genome size of approximately 2.5 megabases (Mb) and GC content of 44.8% [58]. 
Another useful strain, Campylobacter rectus 314,  is a clinical strain isolated from a 
periodontitis patient [22]. C. rectus 314 was sequenced by our lab in 2016 and found to 
also have a genome size of 2.5 Mb, with a comparable GC content of 44.9%. Studies 
using 33238 and 314 are described in this thesis. 
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Inflammation and periodontal disease 
Periodontal disease (PD) affects millions of Americans and is an inflammatory 
disease affecting the supporting tissues and structures surrounding the teeth [59]. PD 
results from oral bacteria localizing in periodontal pockets and stimulating a response 
from the host, such as inflammation [60, 61]. This chronic inflammation can lead to the 
destruction of gum tissues, bone, and tooth-supporting structures [62]. First evidence of 
host response participation in PD was demonstrated when treatment with a prostaglandin 
inhibitor reduced the levels of bone loss [63]. Furthermore, studies involving a non-
human primate model suggested cytokines play a significant role in PD, finding 
inhibition of IL-1 and tumor necrosis factor (TNF) slows the progression of periodontal 
bone loss and detachment [64, 65]. More evidence supporting the role of cytokines in 
PD include a study demonstrating significant levels of IL-1β in gingival tissue from 
periodontitis patients while no IL-1β was detectable in patients with normal gingival 
tissue [66].  
Pro-inflammatory cytokines, like interferon-gamma (IFN-γ), IL-6 and TNF, are 
thought to play a destructive role in the host, as mice deficient for these receptors 
exhibited reduced bone loss in oral gavage models infected with P. gingivalis or A. 
actinomycetemcomitans  [67, 68]. IL-6 has been found to be produced from gingival 
mononuclear cells only in adults with PD [69]. Chemokines also affect PD bone loss by 
recruiting neutrophils, which aid in protection against bacterial invasion. A study 
investigating the chemokine receptor CXCR2 found an increase in periodontal bone loss 
when CXCR-2 deficient mice were given an oral gavage of P. gingivalis when compared 
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to wild-type mice [70]. This study suggests chemokines are a major contributor in the 
protection of the host from bacterial-induced bone loss. 
In summary, previous studies suggest the nature of cytokines and chemokines 
produced by the host response is an important factor in determining if a bacterial 
infection is able to localize in the oral cavity and the extent of gum tissue and bone 
damage caused in response to the infection. 
Rationale and summary of experiments  
Campylobacter rectus has been recognized as a major contributor in periodontal 
disease and other adverse human health outcomes, however the molecular methods of 
pathogenesis are not well-understood. The goal of this thesis was to begin to elucidate 
and characterize virulence mechanisms underlying C. rectus pathogenesis through 
bacterial-host interaction assays to identify host responses related to two secretion 
systems (T3SS and T6SS).  In particular the importance of the CiaB protein to host 
response, as well as the role of the Hcp protein in host cell adherence was investigated. 
Toward this goal, complete deletions of the ciaB and hcp genes have been generated in 
C. rectus.  These mutant strains were used to complete the following specific aims: 
Aim 1: Establish stable reference genes for RT-qPCR in Campylobacter rectus 
One important aspect of studying the involvement of a gene in pathogenesis is the 
ability to measure the expression levels under a variety of conditions through the use of 
reverse transcription quantitative PCR (RT-qPCR). However, it is imperative to 
normalize gene expression to obtain accurate RT-qPCR results. In order to establish 
normalized expression, reference gene (such as housekeeping genes) are commonly used 
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to determine relative expression of a stably expressed target gene [71]. The stability of 
many reference genes used in bacterial gene expression studies have been validated prior 
to analysis, however many are used without verification [72]. Additionally, it is 
important to establish more than one reference gene that will reduce strain-to-strain 
expression variation. Once stable reference genes are established in a bacterium, RT-
qPCR can be used as a helpful tool to provide insight into the many aspects of bacterial 
pathogenesis. Prior to the studies described in this thesis, no published studies had 
investigated global gene expression in C. rectus, meaning stable reference genes were 
not available for this emerging pathogen. Determining the best reference genes is helpful 
in understanding expression patterns and regulation of virulence-associated genes in C. 
rectus. Additionally, the validation of reference genes permitted the assessment of 
transcriptional polarity for mutated regions and assist with confirmation of mutant status. 
Aim 2: Determine the role of CiaB in host cell immune expression  
Previous research has shown bacterial-host interactions with C. rectus induce various 
host responses such as the in vitro secretion of pro-inflammatory cytokines [73, 74]. In 
C. jejuni, CiaB induces secretion of IL-1β and is responsible for the secretion of other 
Cia proteins, such as CiaD, which is found to stimulate the secretion of IL-8 [42, 43, 75]. 
In this project, we focused on the role of CiaB in host cell immune gene expression in 
response to interactions with C. rectus CiaB. Assessment of the ciaB function was based 
on measuring mRNA expression of human genes associated with Gram-negative 
bacterial infections using RT-qPCR. 
  12 
Aim 3: Assess the role of CiaB in host cell viability 
Pathogens induce host cell death as a mechanism to exploit host cells in order to 
establish an infection. Earlier studies have shown the loss of function of the CiaB protein 
in C. jejuni decreases apoptosis by 50 percent in differentiated human THP-1 cells 
(human monocyte, ATCC TIB-202) [75]. Previous research has found CiaB in C. rectus 
has a similar function to CiaB in C. jejuni [38], therefore, it was anticipated that CiaB 
would cause a decrease host cell viability. Host cell viability was measured using a cell 
culture-based assay utilizing trypan blue [30, 31].  
Aim 4: Evaluate the impact of the type VI secretion system (T6SS) Hcp protein in 
adherence efficiencies in Campylobacter rectus 
Adherence to host cells is common among pathogenic bacteria. The T6SS in 
several related bacteria has been found to be critical to the adherence and invasion of 
host cells. In C. jejuni, a 50% reduction in both adherence and invasion to colon 
epithelial and macrophage cells was observed in T6SS mutants, including deletions in 
genes responsible for the Hcp secreted protein and a T6 structural protein [55]. However, 
the T6SS has been found in H. hepaticus to decrease host cell adherence and invasion 
[56].  It was hypothesized that T6SS is critical to the pathogenesis of C. rectus, in 
particular, host cell adherence rates of a C. rectus Δhcp mutant was examined. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Bacterial isolates and routine growth conditions 
Two strains of C. rectus were used in the experiments in this thesis:  33238, a 
strain isolated from a periodontal pocket [57] and 314, a clinical strain isolated from a 
periodontitis patient [22]. Both strains were routinely grown on Mycoplasma formate 
fumarate liquid and agar media (MFF) (Mycoplasma Broth Base 20 g/L, 0.2% sodium 
formate, 0.2% ammonium fumarate) at 37°C in anaerobic conditions (5% CO2, 10% H2, 
85% N2) [4]. C. rectus mutant strains were routinely grown on MFF agar media 
containing 100 µg/mL spectinomycin.  
Bacterial growth conditions to find reference genes 
Prior to RNA extraction, C. rectus 33238 and 314 were inoculated into 5 mL of 
either MFF broth or tryptic soy broth containing formate fumarate (TSBFF) (tryptic soy 
broth 30 g/L, 0.2% sodium formate, 0.2% ammonium fumarate) and grown 
anaerobically for 8 hr at 37°C. Following the incubation period, these cultures were used 
to inoculate 50 mL of MFF or TSBFF, respectively, to an optical density at 600 nm 
(OD600) of 0.02. Cultures were grown overnight at 37°C to an OD600 of 0.25. Once the 
desired OD was achieved, 3 mL was removed from each culture and centrifuged at 
14,800 rpm for 1 min. The supernatant was removed and cultures were resuspended in 
750 µl of RNALater (Thermo Fisher Scientific, Waltham, MA, USA). Four biological 
replicates were analyzed per media type.  
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Bacterial RNA isolation 
After at least a 10 min incubation in RNALater (Thermo Fisher Scientific, 
Waltham, MA, USA), RNA was extracted using the RNeasy Mini Kit (Qiagen, 
Valenica, CA, USA) following the manufacturer’s instructions (RNAprotect Bacteria 
Reagent Handbook) with the following modifications: samples suspended in RNALater 
(Thermo Fisher Scientific, Waltham, MA, USA) were centrifuged at 14,800 rpm for 1 
min. The supernatant was removed and samples were resuspended in 200 µl of ice-cold 
lysis buffer (20 mM Tris pH 7.5, 10 mM EDTA pH 8.0, 150 mM β-mercaptoethanol, 
0.5% SDS, 150 µg/mL proteinase K). Samples were then incubated for 5 min on ice and 
then for 5 min at 65°C. Following incubation, steps 9-10 of protocol 4 from Qiagen’s 
RNAprotect Bacteria reagent handbook (Enyzmatic Lysis and Proteinase K Digestion of 
Bacteria; Qiagen) were performed, followed by step 1 of the manufacturer’s protocol 7 
(Purification of Total RNA from Bacterial Lysate Using the RNeasy Mini Kit), including 
the optional treatment using RNase-Free DNase Set (Qiagen, Valenica, CA, USA) for 
on-column DNase digestion. To eliminate any DNA still present, another DNase digest 
was performed with the DNA-free DNA Removal Kit (Thermo Fisher Scientific, 
Waltham, MA, USA), adding 3 µL each of DNase and 10X DNase I Buffer to 24 µL of 
RNA from each sample, incubating for 90-min at 37°C. Post-incubation, 6 µL of DNase 
inactivation reagent was added to inactivate the DNase. Samples were incubated at room 
temperature with the inactivation reagent for 2 min before being centrifuged at 10,000 
rpm for 90 sec. Supernatants were removed and stored at -20ºC. 
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Bacterial RNA quality and quantification 
RNA samples were tested for any remaining DNA presence using PCR with 
primers for glyA and rpoA targets (Table 1). PCR was performed using the Qiagen Taq 
PCR Core kit (Qiagen, Valencia, CA, USA) with final concentrations of 1X coral load 
buffer, 0.2 mM dNTPs, 0.4 µM forward and reverse primers, and 0.625 units of Taq 
polymerase, using the following parameters on a Bio-Rad C1000 Touch Thermal Cycler 
(Bio-Rad Laboratories, Hercules, CA, USA): 94°C for 3 min, then 35 cycles of: 94°C 30 
sec, 55°C 30 sec, 72°C 1 min, with a final elongation of 72°C for 5 min. Once RNA 
samples were determined to be DNA-free, samples were quantified using a Qubit 
Fluorometer 2.0 (ThermoFisher Scientific, Waltham, MA, USA), according to 
manufacturer’s instructions. RNA quality was visualized following manufacturer’s 
protocol on the Agilent 2200 TapeStation (Agilent Technologies, Santa Clara, CA, 
USA). 
Quantitative reverse transcription PCR for bacterial reference genes 
 The following commonly used bacterial reference genes were validated in C. 
rectus 33238 and 314 using RT-qPCR: 16S ribosomal RNA (16S), DNA gyrase (gyrA), 
recombinase A (recA), serine hydroxymethyltransferase (glyA), RNA polymerase 
(rpoA), and RNA polymerase sigma factor (rpoD) [72].  RT-qPCR was performed on a 
Bio-Rad C1000 Touch Thermal Cycler with the CFX96 Real-Time System with the iTaq 
Universal SYBR Green One-Step Kit according to manufacturer’s instructions for 10 µL 
reactions using 250 ng RNA from each sample. The thermocycler was set to the 
following parameters: 10 min at 50°C, 1 min at 95°C, followed by 40 cycles of 95°C 15 
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sec, 55°C 15 sec, 72°C 30 sec, with a 65-95°C melt curve analysis with 0.5°C increase 
and 5 sec per cycle. Reactions were performed with primers for the six different 
reference genes (Table 1) with no template controls included for each primer set. 
Additionally, no reverse transcriptase controls for all samples were included using the 
glyA and rpoA primer sets. Results were analyzed using BestKeeper and NormFinder 
programs [76, 77]. Statistical differences between quantification cycle (Cq) values in 
each media condition were calculated using a Student t-test using JMP 12 Pro software 
(SAS, Cary, NC, USA).  
Bacterial mutant generation 
A complete gene replacement of the ciaB gene was constructed in C. rectus 
33238 as previously described by Blackburn, et al. [38]. A complete deletion of the hcp 
gene was generated in C. rectus 33238 by the DS Threadgill lab using the Gibson 
Assembly Kit (New England Biolabs, Ipswich, MA, USA) following manufacturer’s 
instructions. Primers were designed for the genes immediately up and downstream of the 
hcp gene and the spectinomycin cassette was inserted into the pUC19 suicide plasmid 
digested with BamH1. All plasmids were sequence verified (Eton Biosciences, Research 
Triangle Park, NC, USA). The suicide plasmid was electroporated into C. rectus 33238 
as previously described [38]. The hcp mutant was verified using PCR screens for the 
presence of specr and the presence of the hcp gene. PCR reactions contained 1X coral 
load buffer, 0.2 mM dNTPs, 0.4 µM of either specr forward and reverse primers or pre-
hcp forward and post-hcp reverse primers (Table 1), 0.625 units of Taq polymerase, and 
nuclease-free water to a final volume of 25 µL. The following parameters were used on a 
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Bio-Rad C1000 Touch Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA): 
94°C for 3 min, then 35 cycles of 94°C 30 sec, 55°C 30 sec, 72°C 1 min, with a final 
elongation of 72°C for 5 min. 
Mutant polar effects and gene expression 
C. rectus wild-type (WT) 33238 and mutant bacterial RNA was extracted 
following the methods previously described [38]. RT-qPCR reactions were performed 
using iTaq Universal SYBR Green Supermix (Bio-Rad C1000 Thermocycler; Bio-Rad) 
under the following parameters: 10 min at 50°C, 1 min at 95°C, followed by 40 cycles of 
95°C 15 sec, 55°C 15 sec, 72°C 30 sec, with a 65-95°C melt curve analysis with 0.5°C 
increase and 5 sec per cycle. Assessment of transcriptional activity included genes 
located upstream and downstream of ciaB and hcp, as well as of the ciaB gene. 
Reactions were performed with primers for the nearest up (pyridine nucleotide-disulfide) 
and downstream acyl-CoA thioester hydrolase genes of ciaB, genes upstream 
(diadenosine tetraphosphate hydrolase) and downstream (Rhs element VgrG protein) of 
hcp, as well as primers designed for the ciaB gene (Table 1) with no template controls 
included for each primer set. Additionally, no reverse transcriptase controls for all 
samples were included using the rpoA primer set. Data were normalized using the three 
recommended C. rectus 33238 reference genes (rpoA, gyrA, and recA). Expression 
analysis was performed using the Bio-Rad’s CFX Manager software and statistical 
analysis of significant differences between WT and mutant gene expression was 
calculated using a Student t-test in JMP 12 Pro software.  
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Growth curves 
 A 36 hr growth curve of C. rectus 33238 WT, Δhcp, and ΔciaB in MFF broth 
was conducted to analyze growth characteristics of each strain. C. rectus 33238 WT, 
ΔciaB, and vhcp strains were inoculated into 5 mL of MFF broth and grown 
anaerobically overnight at 37°C. Following the incubation period, these cultures were 
used to inoculate 5 mL of MFF broth to an OD600 of 0.01. The OD600 was read every 4 hr 
for 36 hr, with the exception of readings at 16 and 20 hr. Differences in growth were 
analyzed using an ANOVA statistical test in JMP Pro 12 statistical software. Three 
biological replicates were analyzed per bacterial strain.  
Identification tests 
 Identification tests were performed on C. rectus 33238 WT and ΔciaB strains to 
ensure no biochemical or motility differences existed between the two strains. Tests 
were conducted as previously described [78]. Tests included alpha-hemolysis on 
Brucella blood agar plates (Anaerobe Systems, Morgan Hill, CA, USA), motility on 
MFF plates containing 0.4% agar [79], oxidase test, Lysine Iron Agar (LIA), Ornithine 
broth, and resistance to the antibiotic Cephalothin (Table 2) [80, 81].  
Human cell culture 
 BeWo cells were generously provided by Dr. Sakhila K. Banu (Texas A&M 
University, College Station, TX, USA) and are derived from a human placenta 
choriocarcinoma (ATCC CCL-98). BeWo cells were routinely cultured in F-12K 
medium (Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) 
supplemented with 10% fetal bovine serum (FBS) (VWR International, Radnor, PA, 
  19 
USA) and Penicillin-Streptomycin (100 U/mL) (Life Technologies, Thermo Fisher 
Scientific, Waltham, MA, USA) at 37°C with 5% CO2. Cells were split 1:4 every 48-72 
hr. THP-1 cells, a human leukemic monocyte cell line (ATCC TIB-202), were routinely 
cultured in RPMI-1640 medium (Life Technologies, Thermo Fisher Scientific, Waltham, 
MA, USA) supplemented with 10% FBS (VWR International, Radnor, PA, USA) and 
penicillin-streptomycin (100 U/mL) (Life Technologies, Thermo Fisher Scientific, 
Waltham, MA, USA) at 37°C with 5% CO2. 
Bacterial growth conditions for assays 
 C. rectus WT 33238, ΔciaB, and Δhcp strains were inoculated into 5 mL of MFF 
broth approximately 20 hr before all host response assays for pre-growth and incubated 
anaerobically for 8 hr. After pre-growth, 5 mL of MFF was inoculated to reach an OD600 
of 0.01 and then diluted by half.  Cultures were then incubated overnight to reach an 
OD600 of 0.15. Bacterial cultures were centrifuged for 2 min at 14,800 rpm and 
resuspended in F-12K or RPMI 1640 cell culture medium supplemented with 1% FBS.  
Host response assays 
Approximately 20 hr prior to host response assays, BeWo cells were washed with 
Dulbecco’s Phosphate-Buffered Saline (DBPS) (Thermo Fisher Scientific, Waltham, 
MA, USA), detached from culture flasks with 0.5% Trypsin EDTA (Thermo Fisher 
Scientific, Waltham, MA, USA), and cell concentrations were determined using a 
Countess Cell Counter (Thermo Fisher Scientific, Waltham, MA, USA) using 
manufacturer’s instructions. BeWo cells were then seeded in 6-well cell culture plates 
(Greiner Bio-One, Monroe, NC, USA) at a density of 5x105 cells in triplicate for each 
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variable. Cells were added in a 2-mL volume of F-12K media supplemented with 10% 
FBS and Penicillin-Streptomycin (100 U/mL) and incubated for 20 hr in 5% CO2 at 
37°C. Approximately 30 min prior to adding bacteria to cells, BeWo cells were washed 
again 3 times with DPBS in order to remove any remaining antibiotic and 2 mL F-12K 
containing 1% FBS was added to each well. C. rectus 33238 WT and mutant strains 
were added to each well to reach a multiplicity of infection (MOI) of 200. E. coli LPS 
(0111:B4 strain; Invivogen, San Diego, CA, USA) was added at a concentration of 2.5 
µg per well as a positive control [73]. Three wells of uninfected cells were included as a 
negative control. Plates were centrifuged at 1000 rpm for 5 min for maximal bacteria-
host contact and incubated anaerobically at 37°C for 6 hr, as previous research testing a 
variety of time points for maximal host cell invasion has indicated maximal C. rectus 
invasion occurs at 5 hr [38]. Additionally, Wang et al. [21] found that maximal host 
mRNA expression and cytokine secretion levels in response to C. rectus occurs after 6 hr 
of bacterial-host exposure. Following the 6 hr incubation period, the supernatant was 
removed from the wells, centrifuged for 5 min at 1500 rpm, removed from the pellet, 
and stored at -20°C for later use [73]. Cells were washed 3 times with DPBS, overlaid 
with 800 µl RNAlater (Thermo Fisher Scientific, Waltham, MA, USA), sealed with 
ParaFilm, and stored at 4ºC. Three biological replicates were conducted per variable.   
BeWo RNA isolation 
 After at least a 48 hr incubation in RNALater (Thermo Fisher Scientific, 
Waltham, MA, USA), RNALater was gently removed from cells by pipetting and total 
eukaryotic RNA was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) 
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per the manufacturer’s instructions (RNeasy Mini Kit Quick-Start Protocol) with the 
following modifications: after homogenization using the QiaShredder (Qiagen, Valencia, 
CA, USA), samples were incubated at room temperature for 5 min prior to the addition 
of fresh 70% ethanol. Samples were also incubated at 55ºC for 5 min after 40 µL RNase-
free water was added to the column, prior to elution. Methods also included the optional 
on-column DNAse digestion treatment. All RNA samples were treated with one 
additional DNase digestion, following methods previously described above using the 
DNA-free DNA Removal Kit (Thermo Fisher Scientific, Waltham, MA, USA) [38]. To 
ensure no DNA was still present, PCR was performed with primers designed for the 
glyceraldehyde-3-phophate dehydrogenase (GAPDH) gene of BeWo cells (Table 1).  
PCR was performed using the Qiagen Taq PCR Core kit (Qiagen, Valenica, CA, 
USA) with final concentrations of 1X coral load buffer, 0.2 mM dNTPs, 0.4 µM forward 
and reverse primers, and 0.625 units of Taq polymerase, using the following parameters 
on a Bio-Rad C1000 Touch Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, 
USA): 94°C for 3 min, then 35 cycles of: 94°C 30 sec, 55°C 30 sec, 72°C 1 min, with a 
final elongation of 72°C for 5 min. RNA samples were quantified and quality was 
evaluated using a Take3 Micro-Volume plate with the Cytation 5 microplate 
spectrophotometer (BioTek, Winooski, VT, USA).  
cDNA synthesis 
One reaction of 15 µL of total RNA from each sample was converted to cDNA 
using the iScript Advance Reverse Transcriptase Supermix (Bio-Rad, Hercules, CA, 
USA) according to the manufacturer’s instructions. cDNA synthesis was initiated by 
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reverse transcription for 20 m at 46ºC followed by RT inactivation for 1 m at 95ºC using 
a Bio-Rad C1000 Touch Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA). 
After conversion, cDNA samples were stored at -20ºC. 
Quantitative reverse transcription PCR for human inflammatory gene expression 
 Expression profiling of a predesigned 96-well gene panel containing genes 
specific to human inflammatory response to Gram-negative infection (Bio-Rad, 
Hercules, CA) was performed using 22 ng cDNA per well. Each qPCR contained 1 µl 
diluted cDNA sample, 1x SsoAdvanced universal SYBR supermix (Bio-Rad, Hercules, 
CA, USA), and 1x PrimePCR assays for the designated target. Reactions were 
performed for three biological replicates per variable at 20 µL final volume per well. 
RT-qPCR was performed using a Bio-Rad C1000 Touch Thermal Cycler with the 
CFX96 Real-Time System (Bio-Rad, Hercules, CA, USA), starting with activation at 
95ºC for 2 min followed by 40 cycles of denaturation at 95 ºC for 5 sec and 
annealing/extension at 60 ºC for 30 sec, and ending with a melt curve in 0.5 ºC 
increments from 65-95ºC at 5 sec/step. For each sample, the level of a given qPCR 
product was normalized to the qPCR levels of three housekeeping genes (GAPDH, TBP, 
and HPRT1). Analysis of data was conducted using Bio-Rad CFX manager. 
Viability assays 
 Approximately 20 hr prior to viability assays, THP-1 cells were centrifuged at 
1,000 rpm for 5 min, resuspended in 50 mL DPBS, and centrifuged again at 1,000 rpm 
for 5 min. Following three washes, cells were resuspended in RPMI-1640 supplemented 
with 1% FBS and seeded in a 24-well tissue culture plate (Greiner Bio-One, Monroe, 
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NC, USA) at a density of 5x105 cells per well and incubated at 37°C with 5% CO2 [30]. 
Upon reaching an OD600 of 0.15, 1 mL of bacterial cells were harvested via 
centrifugation for 2 min at 14,800 rpm, resuspended in 1 mL RPMI-1640 with 1% FBS, 
and added to each respective well at an MOI of 100 [30]. Plates were incubated at 37°C 
in anaerobic conditions for 24, 36, 72, and 96 hr [21, 30, 38]. At each time point, 
viability of THP-1 cells was calculated using a Countess Cell Counter (Invitrogen, 
Thermo Fisher Scientific, Waltham, MA, USA) per manufacturer’s instructions. A 
positive control of 10 µg/mL of E. coli LPS (0111:B4 strain; Invivogen, San Diego, CA, 
USA) was included [82]. Uninfected cells were used as a negative control and each 
variable was conducted in biological triplicates. At every time point, cell viability for 
each well was calculated in duplicate. Significant differences in viability were analyzed 
using an ANOVA statistical test by JMP 12 software.  
Adherence assays 
BeWo cells were washed with DPBS, detached from culture flasks with 0.5% 
trypsin, and cell concentrations were determined with a Countess Cell Counter (Thermo 
Fisher Scientific, Waltham, MA, USA) following manufacturer’s protocol. Cells were 
then seeded in 24-well tissue culture plates (Greiner Bio-One, Monroe, NC, USA) with 
1x105 BeWo cells and incubated at 37°C with 5% CO2 for 20 hr [38]. About 30 min 
prior to adding bacteria, BeWo cells were washed 3 times with DPBS and covered with 
1 mL of F12-K medium containing 1% FBS. When bacterial cultures reached an OD600 
of 0.15, BeWo cells were washed 3 times with DPBS to remove any remaining antibiotic 
presence before 250 µL fresh media was added to each well. Bacterial cells were added 
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at an MOI of 100 to each well after preparation as described above and plates were 
centrifuged at 1000 rpm for 5 min. Plates were incubated at 37°C in anaerobic conditions 
for 1 hr [21, 38]. After incubation, wells were washed three times with DPBS and 250 
µL of 0.25% trypsin was added to each well for 5 min. Cells were collected into sterile 
microcentrifuge tubes containing cell medium with 1% FBS to inhibit the trypsin. 
Samples were serially diluted and plated on MFF agar in anaerobic conditions. 
Following 48-72 h incubation, CFUs were counted and the percent adherence rate was 
determined based on the total number of bacteria recovered divided by initial bacterial 
input.  
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CHAPTER III 
RESULTS 
 
Analysis of reference genes 
All of the potential reference genes, except the 16S rRNA gene, were used for 
gene stability analysis as the 16S Cq values were too low for analysis. There was no 
significant difference in Cq values for each reference gene between samples grown in 
MFF and TSBFF with the exception of C. rectus 33238 gyrA Cq levels (P<0.05) (Figure 
1). This gene was still included in analysis as the difference in Cq values was minor. 
According to the BestKeeper program analyses, there was not one shared reference gene 
that was the most stable for both strains of C. rectus (Table 3), however the top three 
most stable genes were the same for both strains. The order of the top three reference 
genes using the BestKeeper software for 33238 were rpoA, recA, and gyrA, while the 
order of the top three reference genes for 314 were recA, rpoD, and gyrA or rpoA. 
BestKeeper stability recommendations are based on pair-wise correlations between each 
sample’s geometric mean, arithmetic mean, minimal and maximal values, standard 
deviations, and coefficient of variances [77]. Analysis using the NormFinder program 
found the top three stable reference genes for strain 33238 to be recA, gyrA, followed by 
rpoA (Table 4). The NormFinder program recommends gyrA, recA, and glyA as the best 
combination of reference genes for strain 314 (Table 4). NormFinder recommendations 
are based on each sample’s coefficient of variation and signal intensity to find estimation 
of expression variation [76]. 
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Mutant gene expression and polar effects 
The ciaB gene was successfully deleted and potential polarity effects were tested. 
PCR and RT-qPCR analysis showed the lack of the ciaB gene and mRNA expression in 
the ciaB mutant (Figure 2). Moreover, no polarity effects were found in mRNA 
expression between WT and the ciaB mutant strains of up and downstream genes (Figure 
2). PCR analysis confirmed the absence of the hcp gene in the hcp mutant (data not 
shown). 
Growth curves 
In order to determine whether wild-type and mutant strains of C. rectus exhibit 
different rates of growth, C. rectus 33238 WT, ΔciaB, and Δhcp strains were grown in 
MFF broth without antibiotics for 48 hr (Figure 3). Growth of C. rectus 33238 WT and 
both mutant strains significantly increased over 24 hr (P<0.05). All three strains reached 
their peak OD600 at 24 h (Figure3). Numbers of viable C. rectus 33238 WT and mutant 
strains decreased significantly after 32 hrs (P<0.05). The only significant difference in 
growth rates was seen at 12 hr, where ΔciaB growth was significantly less than the other 
two strains (P<0.01). 
Identification tests 
To determine if any unexpected phenotypic differences (i.e., those not expected 
to result from deletion of ciaB) between C. rectus 33238 WT and ΔciaB strains existed, 
several biochemical tests were performed. Both strains had similar amounts of motility 
in 0.4% agar, tested positive for alpha-hemolysis, and oxidase activity and negative for 
lysine-iron agar. No growth was visualized in the ornithine decarboyxylase test. Both 
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strains were susceptible to the antibiotic Cephalothin (Table 2). Results indicated no 
unexpected phenotypic differences between WT and ΔciaB strains.  
Host response assays 
In order to assess the role of the ciaB gene in host cell response, C. rectus 33238 
WT and ΔciaB strains were exposed to BeWo cells for 6 hr. BeWo mRNA expression 
levels were assessed using the Bio-Rad predesigned assay specific for 88 genes common 
in human inflammatory response to Gram-negative bacteria. Overall, a trend in 
upregulation of BeWo inflammatory mRNA expression was seen in response to C. 
rectus 33238 compared to expression from uninfected BeWo cells, however the pro-
inflammatory response to ΔciaB was greater than the response to WT. Results show 41 
genes were significantly upregulated in response to ΔciaB (Table 5). Some of the most 
significant genes include IL-8, TGFBR2, and TNF (P<0.001), CASP7, CCR7, CD14, 
EGR1, IL-6, LGALS3BP, PTGS2, RAF1, TLR4, TNFRSF1A, TNFRSF1B, and TRIM 
25 (P<0.01), and CXCL2, MGMT, and SOCS3 (P<0.05) (Figure 4). In comparison, 3 
genes were significantly upregulated in response to WT, including PTGS2, TNF and 
TRIM25 (P<0.05). Additionally, 6 genes had a statistical trend in upregulation in 
response to WT: IL-8, CD14, MGMT, CCR7, CXCL2, and TNFRSF1B (P<0.1) (Figure 
4). BeWo cell responses to the positive control, E. coli LPS, were upregulated for 
several genes, including CD14 (2.04±0.50) and IL-8 (37.94±22.35) (Table 5).  
Viability assays 
Viability of undifferentiated THP-1 monocytes was measured after exposure to 
C. rectus 33238 WT and ΔciaB strains over a 96 hr time period. The effects of C. rectus 
  28 
33238 WT and ΔciaB strains on cell viability are seen in Figure 5. There is no significant 
difference between the viability of THP-1 monocytes when challenged with C. rectus 
33238 WT or ΔciaB strains. However, there was a significant decrease in the viability of 
the uninfected cells versus those challenged with WT or ΔciaB at the 24 and 96 hr time 
points (P<0.01). Cells infected with 10 µg/mL E. coli LPS (0111:B4 strain) were 
significantly less viable than uninfected cells at every time point (P<0.01). Cell viability 
when infected with E. coli LPS-infected cells was significantly lower than uninfected 
cells at every time point (P<0.01). The viability of unchallenged cells only significantly 
decreased after 96 hr (P<0.05).  
Adherence assays 
The role of the T6SS Hcp protein was assessed in the ability of C. rectus to 
adhere to host cells. After a 1 hr incubation time with BeWo cells, the adherence 
efficiency of C. rectus Δhcp was not significantly different than that of the C. rectus 
33238 WT strain (Figure 6).  
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CHAPTER IV 
DISCUSSION 
 
This study was performed to further elucidate important virulence mechanisms of 
Campylobacter rectus. More specifically, the role of two proteins, CiaB and Hcp, in host 
cell interactions was investigated. Both proteins are associated with secretion systems 
and contribute to pathogenesis in closely related species [38, 42, 55, 56]. 
To date, little has been discovered about the molecular methods behind C. rectus 
pathogenesis. Earlier research has identified several virulence factors, such as 
lipopolysaccharide, a surface layer protein, cytotoxic activity, chemotaxis, and other 
effector proteins like Campylobacter invasion antigen proteins (Cia) [20, 25, 31, 37, 83]. 
Furthermore, C. rectus s-layer protein is crucial for host cell adherence and immune 
evasion while CiaB is important in the invasion of human placental cells [38]. This is 
important in the ability of C. rectus to colonize in locations other than in the oral cavity. 
The goals of this study were to: a) establish stable reference genes for RT-qPCR in 
C. rectus, b) determine the role of CiaB in host cell immune expression and secretion, c) 
assess the role of CiaB in host cell viability, and d) evaluate the impact of Hcp in host 
cell adherence efficiencies. 
Reference genes 
 RT-qPCR has become an important tool in molecular biology for measuring gene 
expression. In order to obtain accurate and reliable results, it is essential to normalize 
gene expression by using internal controls such as reference genes that are stably 
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expressed under a variety of conditions. In this study, six commonly used reference 
genes were tested. The 16S samples were excluded from the study because the Cq values 
were too low for analysis, likely due to the abundance of rRNA compared to mRNA 
present in the 16S total RNA samples. The sample could have been diluted, however 
doing so could introduce new potential errors [71]. Because the top most stable reference 
genes slightly varied between the BestKeeper and NormFinder, finding stable reference 
genes may not be as straight forward as picking the three most stable reference genes in 
one strain and applying it to all strains. Ideal reference genes have the possibility of 
varying from strain to strain due to variations between strains, meaning each strain used 
in RT-qPCR would need to have reference genes validated prior to expression analyses. 
Using at least recA and gyrA as reference genes in C. rectus RT-qPCR studies could be a 
reasonable alternative as these two genes were selected as the most stable in both C. 
rectus 3328 and 314 by two different statistical programs. Establishing stable reference 
genes for RT-qPCR for C. rectus was fundamental in this thesis in allowing a) the 
assessment of transcriptional polarity effects due to the deletion mutations, and b) the 
sampling of gene expression for mutant strains versus wild-type strains to help 
characterize mutant strains.                                                                                                                                                                                                                                                                                          
Mutant characterization 
This research utilized the identified reference genes for C. rectus to assess 
transcriptional polarity effects caused by the ciaB and hcp mutations and to ensure the 
ciaB deletion mutant had no measurable ciaB mRNA expression (Figure 2). The 
investigation of transcriptional polarity effects and loss of expression for deleted genes is 
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an effective process to confirm observed phenotypic differences are likely due to the 
mutated gene alone. This is especially important as no molecular tools currently exist to 
complement mutations in C. rectus. No significant changes in up or downstream gene 
expression was observed in either of the mutant strains, implying the phenotypic 
characterization observed was due solely to the single gene deleted. Additionally, 
expression of the ciaB gene was absent in the ciaB deletion mutant, confirming, as 
expected, the loss of function of the ciaB gene. Additional experiments are necessary in 
order to verify the hcp gene is no longer being expressed in the hcp mutant strain. 
Other methods utilized in this research to determine if the deletions of the ciaB 
and hcp genes caused any unexpected phenotypic differences from the WT included 
growth curves (Figure 3) and previously established biochemical tests commonly used 
for Campylobacter identification (Table 2) [81]. No significant changes in growth were 
observed between the WT and mutant strains, indicating the deletion of the ciaB and hcp 
genes had no unexpected effects on growth. Additionally, no difference was seen 
between the mutant and WT strains in any of the biochemical tests, further indicating the 
unique phenotypes seen for the mutant are likely due to the engineered mutation alone 
and not any other underlying effects such as rearrangements due to mutagenesis [78, 81]. 
Host response 
In the present study, the host response of BeWo cells to C. rectus 33238 WT and 
ciaB mutant was measured, using RT-qPCR to assess mRNA expression of 88 genes 
commonly associated with human Gram-negative bacterial infections. Although C. 
rectus is an oral pathogen, initial studies on C. rectus host interactions include a variety 
  32 
of human cells lines, likely because C. rectus has been isolated from other areas of the 
body such as the placenta, brain, and lungs [13, 21, 38, 73]. Human placental cells were 
chosen for this study as previous research has revealed C. rectus is capable of invading 
BeWo placental cells and also creates a higher risk of adverse pregnancy outcomes for 
the affected individual [38, 73]. 
Pro-inflammatory activity was observed in the BeWo cell line in response to C. 
rectus 33238 WT and ΔciaB. However, an increased pro-inflammatory response was 
seen in response to the mutant strain (Figure 4), indicating CiaB may contribute to 
evasion of the host immune response. LPS is a potent activator of the host cell response 
involving the CD14 and mammalian Toll-like receptor (TLR) 4 system, which were both 
upregulated in the presence of C. rectus 33238 WT and ΔciaB. This response to both 
strains was anticipated to stimulate CD14 and TLR4, as C. rectus produces LPS [16]. In 
placental cells, activation of the TLR4 signaling pathway stimulates the NF-κB signaling 
cascade [84]. Many of the genes seen upregulated in this study are involved in one or 
both of these pathways [85-87]. Genes in these pathways, including the ones upregulated 
in this study, are responsible for pro-inflammatory responses such as cytokine release, 
DNA repair, cell signaling, leukocyte recruitment and activation, and host apoptosis [85-
88]. 
Of the 41 genes upregulated in response to C. rectus ΔciaB or WT, most were 
involved in inflammation and cell proliferation. Because more pro-inflammatory genes 
were upregulated in the presence of ΔciaB, it is suggested the presence of CiaB 
predominately suppresses the immune system rather than stimulates it. CD14 and TLR4 
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recognize the LPS of Gram-negative bacteria and activate the response system that 
induces pro-inflammatory genes such as TNF, IL-6, IL-8, and PTGS2 [89]. Other genes 
significantly upregulated are responsible for cell signaling, such as LGALS3BP, 
TNFRSF1A, TNFRSF1B, TGFB2, TRIM25, and SOCS3 [90]. Interestingly, TRIM25 
plays a role in inducing cytokines in the RIG-I-like receptor signaling pathway, which is 
known for viral RNA recognition in the NF-κB pathway [91]. However, TRIM25 has 
also been found to regulate ubiquitination of the protein K63, which is involved in signal 
transduction pathways as well as trafficking of targeted proteins [91]. 
Further support of the increased inflammatory response triggered by ΔciaB 
includes the increased mRNA expression from genes involved in recruitment and 
activation of leukocytes and T-cells, like CCR7, CXCL2, and CSF2 [90]. EGR1 mRNA 
expression was also upregulated in response to the ciaB mutant strain. EGR1 is involved 
in cell proliferation and is found to regulate pro-inflammatory gene expression in human 
placental cells [92, 93]. The upregulation o a cell proliferation involved gene in this 
study further supports the increased inflammatory response triggered by ΔciaB.  
Overall, the increase in pro-inflammatory expression when CiaB is not present 
suggests CiaB plays an anti-inflammatory role in C. rectus and aids the bacterium in the 
evasion of the immune system. Although the specific host response to CiaB has not been 
investigated in C. jejuni, results from this study are somewhat contradictory to what was 
anticipated. While there have been no other Cia proteins detected in C. rectus, CiaB in 
C. jejuni is responsible for the secretion of other Cia proteins, such as CiaD, which is 
found to be responsible for stimulating the secretion of IL-8 [43]. However, the CiaI 
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protein in C. jejuni enhances bacterial survival within human epithelial cells by 
preventing host lysosomes from eliminating internalized C. jejuni [40]. Because C. 
rectus CiaB appears to play a role in the invasion of host cells, it would be expected that 
inflammation would decrease because fewer bacteria were able to invade. Similar to C. 
jejuni WT and ciaB mutant strains [42], C. rectus WT and ciaB mutant host cell invasion 
rates are less than 5% [38]. CiaB could also possess functions other than host invasion, 
such as assisting in intracellular survival. Further studies are necessary to fully 
understand the mechanism by which CiaB impacts inflammation, such as examining 
mRNA expression of more genes associated with the innate immune system, measuring 
secreted cytokine levels, and assessing different time points throughout the bacterial-host 
interaction. 
Viability 
 Functional monocyte and macrophage cells are essential components of the 
immune system and response to infection in numerous ways, such as inflammation and 
cell proliferation [94]. Previous research has found C. rectus 33238 to suppress 
proliferation of uninduced promyelocytic cells (HL-60) and is lethal to induced HL-60 
cells [30]. The present study expanded upon prior knowledge and incorporated the THP-
1 human monoyctic cell line, testing the effects of CiaB on cell viability. No significant 
change in viability was seen between C. rectus WT or ΔciaB, implying CiaB does not 
have an effect on undifferentiated THP-1 viability. However, THP-1 cell viability of 
cells exposed to WT or ΔciaB was significantly less than unchallenged cells at 24 hr and 
96 hr, indicating the presence of C. rectus may have an impact. The viability of 
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uninfected cells was only significantly less after 96 hr, indicating THP-1 cells could 
survive in anaerobic conditions, however the assay may benefit from different 
conditions, such as exposing the cells to bacteria under anaerobic conditions for 5 hr, 
then transferring to normal cell culture conditions (37°C in 5% CO2). This would 
provide enough time for the bacteria to potentially invade the THP-1 cells before being 
transferred to the optimal environment for the THP-1 cells. Additionally, further 
experiments are necessary to determine if CiaB has an impact on the viability of 
differentiated THP-1 cells, as differentiation induces THP-1 cells into a macrophage-like 
phenotype and thus enhances cellular responses [95].  
Adherence 
Secretion systems and effector proteins are important contributors to bacterial 
pathogenesis. In C. rectus, the CiaB protein is partly responsible for impacting host cell 
invasion [38], and was determined by this study to play a role in pro-inflammatory 
activity in the host. The research in this thesis also provides some preliminary insight 
into the involvement of the Hcp protein from the type VI secretion system in C. rectus 
pathogenesis, specifically focusing on adherence to host cells. This was done to establish 
whether a difference would be seen in adherence when the hcp gene was deleted, as 
earlier research has indicated the T6SS is involved in adhering to host cells [55, 56]. 
Although no difference was observed in adherence efficiencies between the WT and hcp 
mutant, adherence could be observed after longer cell exposure, or, Hcp could play an 
important role in host cell invasion. If future experiments elucidate no role in host 
  36 
invasion, Hcp could potentially contribute to other methods of virulence such as biofilm 
formation or bacterial competition [96].  
Research in C. jejuni involving T6SS found a significant decrease in both 
adherence and invasion of host cells when hcp is deleted [55]. Subsequently, in studies 
involving H. hepaticus, a significant change in host adherence was not observed between 
WT and an hcp mutant until after a 6 hr exposure [56]. In the present study, adherence 
was only observed after a 1 hr bacterial exposure. Previous studies involving C. rectus 
CiaB have shown the deletion of ciaB does not impact adherence efficiencies but 
reduces host cell invasion [38], indicating additional studies will be needed to determine 
whether there is a difference in invasion frequency of the hcp mutant. 
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CHAPTER V 
CONCLUSIONS 
 
This study has identified optimal reference genes for use in RT-qPCR analysis of 
the importance of CiaB and Hcp in Campylobacter rectus pathogenesis as assessed by 
the stimulation of a response from host cells for CiaB, and adherence (prelude to 
invasion) to host cells for Hcp. The ability of CiaB to stimulate a host response from 
human placental cells likely contributes to the virulence of C. rectus and its ability to 
cause adverse health effects especially during pregnancy. Based on results found in this 
research, future studies can more efficiently and thoroughly investigate mechanisms of 
pathogenesis in this bacterium. For example, CiaB is secreted via the flagellar type III 
secretion system in Campylobacter jejuni and requires a stimulatory signal for secretion 
[42, 53, 97], however, the secretion mechanism of CiaB has yet to be investigated in C. 
rectus. Additionally, the type VI secretion system (T6SS) and one of the secreted T6 
proteins, Hcp, has been found in both the related species Campylobacter jejuni and 
Helicobacter hepaticus to play an important role in pathogenic events such as host cell 
adherence, invasion, and immune response stimulation or evasion [55, 56]. In C. rectus, 
the role of Hcp is still unclear, as host adherence levels were not affected in this 
research. 
The work in this thesis has provided further insight into virulence mechanisms in 
C. rectus and opened avenues for future research involving the role of secretion systems 
and effector proteins in C. rectus pathogenesis. The studies described in this thesis are 
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foundational to future studies related to host response to C. rectus mutants as measured 
by gene expression. Future investigations should be directed toward: a) determining if 
CiaB is a secreted protein; b) measuring ciaB mRNA expression in response to various 
stimulants such as hormones and the presence of host cells; and c) assessing the role Hcp 
plays in C. rectus host cell invasion efficiency and host response stimulation. 
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APPENDIX A 
FIGURES 
  
Figure 1. Observed Cq values of 5 reference genes from RT-
qPCR. The Cq values of the potential reference genes in C. rectus 
strains 33238 (A) and 314 (B), were used in the determination of 
reference genes by BestKeeper and NormFinder. Dark gray bars 
indicate Cq values after growth in MFF broth and light gray bars 
indicate Cq values after growth in TSBFF broth. Statistical 
differences between culture conditions are denoted by a single 
asterisk (P<0.05). Error bars represent standard deviation. 
A) 
 
 
 
 
 
B) 
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Figure 2. C. rectus gene mRNA expression. The expression levels of C. rectus 
33238 wild-type and ΔciaB (A) and Δhcp (B). mRNA expression was normalized to 
the amount of reference genes including recA, gyrA, and rpoA RT-qPCR product 
from the same samples. Statistical differences between relative normalized gene 
expression are denoted by a triple asterisk (P<0.001). Error bars represent standard 
deviation.  
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Figure 3. Growth curve of C. rectus 33238 wild-type, ΔciaB, 
and Δhcp. Spectrophotometric analysis (OD 600 nm) was 
recorded at 0, 4, 8, 12, 24, 28, 32, 36, and 40 hr. The growth of  
ΔciaB was significantly less than that of WT of Δhcp at 12 hr and 
is denoted by a double asterisk (P<0.01). Error bars represent 
standard deviation. 
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Figure 4. mRNA expression levels of BeWo cells when challenged with C. rectus 
33238 wild-type or ΔciaB. The mRNA expression levels of uninfected BeWo cells, or 
BeWo cells infected with C. rectus 33238 wild-type or ΔciaB. mRNA expression was 
normalized to the amount of reference genes including GAPDH, HPRT1, and TBP RT-
qPCR product from the same samples. Statistical differences between gene expression 
are denoted as follows: ***= P<0.001, ** = P<0.01, * = P<0.05,  
# = P<0.1. Error bars represent standard deviation.  
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Figure 5. Viability assay of undifferentiated THP-1 monocytes. 
Viability of THP-1 monocytes was recorded at 0, 24, 48, 72, and 
96 hr. As compared with the uninfected THP-1 cells, the viability 
of C. rectus WT infected cells was significantly different at 24 hr 
(P<0.1) and 96 hr (P<0.01); viability of ΔciaB infected cells were 
significantly lower than uninfected cells at 24 hr (P<0.05), 72 hr 
(P<0.1) and 96 hr (P<0.01); viability of LPS infected cells was 
significantly decreased compared to uninfected THP-1 cells at 24 
hr (P<0.01), 48 hr (P<0.01), 72 hr (P<0.01), and 96 hr (P<0.01). 
Error bars represent standard deviation. 
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Figure 6. Adherence efficiency of C. rectus 33238 wild-type 
and Δhcp. Adherence efficiencies to BeWo cells were calculated 
after a 1 hr exposure. Serial dilutions of input bacteria and output 
bacteria were plated and used to calculate adherence efficiencies, 
dividing total number of output bacteria recovered by initial 
bacterial input. Adherence efficiencies between WT and Δhcp are 
not significantly different. Error bars represent standard deviation.  
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APPENDIX B 
TABLES 
 
Table 1. Primers used in this study. 
Target Gene Forward Primer Reverse Primer 
16S CGGTACCCAAGGAATAAGCA TCCTTTACGCCCAGTGATTC 
gyrA AAAAACGGCATCGTAAAACG GCTCGTCGTTCTCGTCTAGG 
recA TCGGACTTGACTTGGCTCTT GCGATGATATGAAGCGTGAG 
glyA AGCGCATATACGCGAGAGAT TACGACTAGACCGGCGATGT 
rpoA CACGCGAAGTTGCTACAAAG CATCCATCAAAGCAAGCTCA 
rpoD CCAGGATGGCAAAGTCAAAT CCGATGTTGCCTTCTTGAAT 
 GGGGACAACTTTGTATAGAAAA
GTTGCGCTGGCGGCCGGCA 
TGAGTT 
GGGGACTGCTTTTTTGTACAAACTTG
GATGGCGATAGCGCGCGAGAC 
specr GGGGACAAGTTTGTACAAAAAA
GCAGGCTGCCGTAACGTG 
ACTGGCAAGAG 
GGGGACCACTTTGTACAAGAAAGCT
GGGTGCAAAAGATTT 
TAGACTAATGGTTAA 
post-ciaB GGGGACAGCTTTCTTGTACAAA
GTGGCGCGCCGGTTCTTTG 
GACGGCT 
GGGGACAACTTTGTATAATAAAGTT
GCCGCGCAAATTTCCC AAACCGC 
ciaB AGCTAAACGGGCTTTTCTCC GCCTTGGCACTCTCGTAAAC 
ciaB 
upstream 
CAGCTTGTCGAGGTGGATAAA CATACGAGGCACGAGATGTAAA 
ciaB 
downstream 
TTTAGAAGGGATGGGCGAAC CTAGGTCGATCTGGCTCATTATC 
pre-hcp ATTCGAGCTCGGTACCCGGGTC
TTCGTTTTCATTTACCCAATG 
TCACGTTACGTTTTACTCCTTTGAAA
AAAATATTCATTATTG 
post-hcp TTTAGAAAACGCTTATAAATTT
AGGAGACTTGTTTTTTG 
CCTGCAGGTCGACTCTAGAGTATCCC
GTTATAAACGGATTC 
hcp 
upstream 
GAGATGAAGCTTGGAGGTGTT AAGAGACGCCAATCAGGTATTT 
hcp 
downstream 
GACGTAATCGAAGGGAGCTATG GTATGCTGAGAGTCGGTGTTT 
GAPDH AGTCAGCCGCATCTTCTTTTGC CTCCTGGAAGATGGTGATGGGA 
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Table 2. Biochemical tests used in this study. 
Test Function WT ciaB 
mutant 
Alpha-hemolysis Detection of the enzyme production capable of 
breaking apart blood cells  
+ + 
Motility To detect presence of bacterial flagella + + 
Oxidase To identify bacteria containing cytochrome 
oxidase enzyme 
+ + 
Lysine Iron Agar 
(LIA) 
Detects bacterial capability to produce Lysine 
Decarboxylase (LDC), Lysine Deaminase 
(LDA) enzymes, and/or Hydrogen Sulfide 
LDA – 
LDC + 
LDA – 
LDC + 
Ornithine Broth Detect bacterial ability to decarboxylate 
ornithine uing the enzyme Ornithine 
Decarboxylase (OCD) 
- - 
Cephalothin resistance Detection of Campylobacter species - - 
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 Table 3. BestKeeper analysis for C. rectus strains 33238 and 314. 
 
  
Strain Gene GM 
[Cq] 
(min, max) 
[Cq] 
SD [±  
Cq] 
(min, max) 
[x-fold] 
SD [±  x-
fold] 
33238 gyrA 16.41 15.88,17.10 0.37 -1.4,1.57 1.27 
 recA 18.29 17.87,19.23 0.33 -1.28,1.77 1.24 
 glyA 21.43 20.04,24.69 0.87 -2.13,6.34 1.76 
 rpoA 12.76 12.37,13.36 0.23 -1.26,1.45 1.16 
 rpoD 16.66 14.93,25.22 2.14 -2.11,82.27 3.99 
314 gyrA 16.67 15.44,17.44 0.46 -2.2,1.67 1.35 
 recA 18.60 17.86,19.31 0.41 -1.56,1.54 1.30 
 glyA 35.38 34.14,37.09 0.59 -1.99,2.62 1.46 
 rpoA 13.00 11.46,13.80 0.46 -2.53,1.65 1.35 
 rpoD 18.37 17.77,19.11 0.42 -1.34,1.45 1.31 
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Table 4. NormFinder Analysis for C. rectus strains 33238 and 314. 
 Stability Value 
Gene 33238 314 
gyrA 0.008 0.016 
recA 0.003 0.016 
glyA 0.027 0.029 
rpoA 0.012 0.032 
rpoD 0.065 0.031 
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Table 5. Genes and normalized relative expression levels with significant changes in 
mRNA expression compared to uninfected BeWo cells.  
(*** = P<0.001, ** = P<0.01, * = P<0.05, # = P<0.1) 
 
Target Function WT ΔciaB E. coli LPS 
AC013461.1 Cell cycle, apoptosis 1.70 ± 0.63 * 1.79 ± 0.2 * 1.81 ± 0.15 * 
AIF1 Apoptosis, anti-
inflammatory 
0.46 ± 0.23 0.54 ± 0.07 # 0.92 ± 0.09 
APOC2 Lipid biding 1.71 ± 0.92 6.87 ± 1.61 * 2.29 ± 0.45 # 
APOL3 Lipid binding 0.28 ± 0.16 # 0.77 ± 0.10 1.19 ± 0.29 
BAX Apoptosis 1.72 ± 0.64 1.87 ± 0.22 * 1.69 ± 0.09 * 
CASP7 Apoptosis 3.13 ± 1.27 3.24 ± 0.24 ** 2.58 ± 0.49 * 
CCR7 Chemokine recognition 23.63 ± 9.85 * 54.74 ± 7.52 * 2.17 ± 0.12 *** 
CD14 Surface antigen 5.01 ± 1.7 * 13.67 ± 0.17 
** 
2.04 ± 0.50 
CD55 Immune cell activation 1.18 ± 0.45 2.31 ± 0.21 # 0.76 ± 0.04 
CSF2 Immune cell activation 2.68 ± 1.69 17.15 ± 5.86 # 2.25 ± 0.22 
CXCL2 Inflammation 6.01 ± 2.97 * 10.83 ± 2.84 # 4.80 ± 1.65 # 
CYP1A1 Lipid synthesis 2.21 ± 0.90 7.61 ± 1.27 ** 0.31 ± 0.02 
EGR1 Cell proliferation 2.36 ± 0.79 8.54 ± 1.14 ** 3.79 ± 0.53 * 
EZH2 Cell differentiation  2.24 ± 0.84 2.70 ± 0.36 ** 1.82 ± 0.16 
FKBP5 Protein transport 2.11 ± 0.76 1.83 ± 0.40 # 1.83 ± 0.44 
FSTL1 Inflammation 1.07 ± 0.65 4.04 ± 0.61 ** 2.67 ± 0.21 * 
GDF15 Cell differentiation 3.44 ± 1.47 7.34 ± 1.07 ** 0.94 ± 0.06 
HLA-DMA Protein transport 2.67 ± 1.06 4.69 ± 0.94 * 2.16 ± 0.17 * 
IL6 Cytokine 1.46 ± 0.52 2.83 ± 0.22 ** 0.34 ± 0.05 * 
IL8 Chemokine 92.54 ± 52.22 # 102.27 ± 
11.85 *** 
37.94 ± 22.34 # 
IRS2 Cell signaling 1.45 ± 0.48 2.21 ± 0.29 * 1.38 ± 0.13 
JUP Protein binding 11.43 ± 5.83 15.47 ± 2.55 * 3.58 ± 0.20 * 
LGALS3BP Cell signaling 8.89 ± 4.95 19.30 ± 2.88 * 3.12 ± 0.42 * 
MBP Apoptosis 2.27 ± 0.99 3.70 ± 0.85 * 0.64 ± 0.11 # 
MCM3 DNA replication 1.63 ± 0.60 1.77 ± 0.16 * 1.27 ± 0.15 
MGMT DNA repair 5.92 ± 2.37 # 12.01 ± 2.45 * 4.22 ± 0.41 ** 
MIF Immune cell recruitment 2.30 ± 0.83 2.21 ± 0.24 ** 2.12 ± 0.23 ** 
MUC1 Cell signaling 1.76 ± 0.69 3.78 ± 0.36 ** 1.42 ± 0.08 
OAS3 Protein synthesis 1.94 ± 0.90 2.94 ± 0.24 ** 1.16 ± 0.09 
PSMA5 Proteasome 0.50 ± 0.16 # 0.54 ± 0.05 * 0.54 ± 0.07 # 
	 	 	 	 	
  60 
Table 5  continued 
Target	 Function	 WT	 ΔciaB	 E. coli LPS	
PSMB8 Proteasome 1.98 ± 0.77 1.84 ± 0.15** 1.32 ± 0.10 * 
PTGS2 Inflammation 9.85 ± 3.16 * 17.14 ± 3.02 ** 0.66 ± 0.05 
RAF1 Apoptosis 3.62 ± 1.39 6.01 ± 0.87 ** 2.60 ± 0.19 * 
SLC6A4 Cell proliferation 1.23 ± 0.55 2.40 ± 0.27 ** 1.29 ± 0.09 
SOCS3 Anti-inflammatory 5.78 ± 2.93 7.95 ± 1.90 * 2.24 ± 0.11 * 
TGFBR1 Cell proliferation 32.55 ± 1.03 3.90 ± 0.39 ** 1.54 ± 0.09 
TGFBR2 Cell proliferation 9.31 ± 4.40 18.36 ± 1.61 
*** 
2.85 ± 0.26 ** 
TLR4 Inflammation 3.14 ± 1.18 8.04 ± 1.32 ** 0.06 ± 0.00 
TMSB10 Cytoskeleton organization 0.83 ± 0.27 0.74 ± 0.07 # 1.00 ± 0.08 
TNF Inflammation 18.54 ± 7.46 * 54.84 ± 4.09 
*** 
0.82 ± 0.61 
TNFRSF1A Cell signaling 2.30 ± 0.93 4.02 ± 0.39 ** 1.73 ± 0.16 # 
TNFRSF1B Cell signaling 8.85 ± 3.81 # 20.71 ± 3.13 ** 2.80 ± 0.54 * 
TRIM25 Transcription factor 4.99 ± 1.36 * 10.12 ± 1.14 ** 13.17 ± 2.74 * 
UBE2L3 Protein binding 0.78 ± 0.24 0.69 ± 0.06 # 0.72 ± 0.10 
VEGFA Cell proliferation 1.31 ± 0.45 2.68 ± 0.34 ** 0.89 ± 0.11 
YWHAZ Cell survival 1.93 ± 0.74 1.97 ± 0.25 * 1.36 ± 0.13 
 
 
